Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.26
+0.09 (1.54%)
At close: Jul 8, 2025, 4:00 PM
6.25
0.00 (-0.08%)
After-hours: Jul 8, 2025, 4:11 PM EDT

Aura Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
388411436389496-
Upgrade
Market Cap Growth
-24.26%-5.92%12.22%-21.59%--
Upgrade
Enterprise Value
278255308298631-
Upgrade
Last Close Price
6.258.228.8610.5016.98-
Upgrade
PB Ratio
2.452.701.931.993.26-
Upgrade
P/TBV Ratio
3.032.701.931.993.26-
Upgrade
Debt / Equity Ratio
0.140.120.090.110.01-
Upgrade
Quick Ratio
10.5210.1318.3018.0620.276.54
Upgrade
Current Ratio
11.0610.7718.7618.8120.906.94
Upgrade
Return on Equity (ROE)
-56.24%-46.01%-36.26%-33.78%-41.07%-88.60%
Upgrade
Return on Assets (ROA)
-32.92%-27.46%-22.18%-19.63%-24.19%-46.92%
Upgrade
Return on Capital (ROIC)
-34.32%-28.87%-23.00%-20.39%-25.52%-55.32%
Upgrade
Earnings Yield
-24.44%-21.17%-17.51%-15.11%-7.11%-
Upgrade
FCF Yield
-20.66%-19.74%-14.79%-14.32%-6.96%-
Upgrade
Buyback Yield / Dilution
-17.12%-25.32%-32.34%-480.18%-1305.21%-8.54%
Upgrade
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q